ABIGO PHARMA A/S: Financial statements 2015
CVR: 12927983
Source: annual report 2015, Danish Business Authority
01/05/2014 – 30/04/2015
ABIGO PHARMA A/S (CVR 12927983) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 3,522,101 and a net result of DKK 778 compared with DKK 91,006 the year before. That is an increase of 27.1% compared with the year before. Equity in the 2015 report amounted to DKK -983,084.
- Gross Profit
- DKK 3,522,101
- Profit/Loss
- DKK 778
- Equity
- DKK -983,084
- Total Assets
- DKK 7,787,176
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 3.5 mio. | 778 | -983 t. | - |
| 2014 | - | 2.8 mio. | 91 t. | -984 t. | - |
| 2013 | - | 2.7 mio. | 85 t. | -1.1 mio. | - |
Official annual report
How creditworthy is ABIGO PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of July 10, 2015, Bjarne Dennis Reffeldt Otte has joined the board of directors of ABIGO PHARMA A/S.
As of July 10, 2015, Claes Dahl has left the board of directors of ABIGO PHARMA A/S.
As of July 10, 2015, Bjarne Dennis Reffeldt Otte is registered as adm. dir. of ABIGO PHARMA A/S.
As of July 10, 2015, Per-Oluf Nilsson is registered as suppleant of ABIGO PHARMA A/S.
As of July 10, 2015, Claes Dahl has stepped down as adm. dir. of ABIGO PHARMA A/S.
As of July 7, 2015, Carl Magnus Anders Elliot is registered as suppleant of ABIGO PHARMA A/S.
About ABIGO PHARMA A/S
ABIGO PHARMA A/S was a Danish company of the type Aktieselskab based in Allerød, founded in 1989. The company has been dissolved on 27 June 2024. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. The company was previously named DHC A/S and DANSK HELSEMIDDEL CENTER A/S. The company has 1 employee (2023). In 2023, the company reported revenue of DKK 9,189,036 and a net result of DKK 201,721 compared with DKK 165,903 the year before. Equity in the 2023 report amounted to DKK 4,838,794.